GGrantIndex
Sort

46,585 grants matching heart failure

ROLE OF CD36 IN NUTRIENT DELIVERY AND ITS DYSFUNCTION IN AFRICAN AMERICANS

$485,027
Nada A. Abumrad · Washington University · R01 · FY2017 · DK

Cardio-Hit Phase II

$484,965
Karen Kmetik · American Medical Association · R18 · FY2007 · HS

CARDIOVASCULAR CALCIFICATION PATHOPHYSIOLOGY &TREATMENT

$484,948
Children'S Hospital Of Philadelphia · R01 · FY2000 · HL

SYMPATHETIC OUTFLOW IN HEART FAILURE: ANG II, NO AND ROS

$484,935
Irving H Zucker · University Of Nebraska Medical Center · P01 · FY2007 · HL

Sympatho-inhibition with Mindfulness in Chronic Kidney Disease

$484,930
Jeanie Park · Emory University · R61 · FY2019 · AT

Effect of Mitral Regurgitation on Ischemic LV Remodeling

$484,912
Massachusetts General Hospital · R01 · FY2005 · HL

Defining the cardiomyocyte microdomain signaling landscape in cardiac hypertrophy

$484,878
Matthew Jacob Brody · University Of Michigan At Ann Arbor · R01 · FY2025 · HL

Defining the cardiomyocyte microdomain signaling landscape in cardiac hypertrophy

$484,878
Matthew Jacob Brody · University Of Michigan At Ann Arbor · R01 · FY2023 · HL

Cell cycle proteins as key regulators of cardiac chemosensitivity

$484,870
Zhaokang Cheng · Washington State University · R01 · FY2023 · HL

Therapeutic targeting of tissue inhibitor-4 in hypertrophy and failure

$484,805
Francis G Spinale · University Of South Carolina At Columbia · R01 · FY2018 · HL

DIAGNOSIS OF LEFT VENTRICULAR ASSIST DEVICE INTRAPUMP THROMBOSIS

$484,793
Gregory M Lanza · Washington University · R01 · FY2015 · HL

AEROSOL FUROSEMIDE FOR DYSPNEA RELIEF: LABORATORY AND CLINICAL STUDIES

$484,782
Robert B Banzett · Beth Israel Deaconess Medical Center · R01 · FY2011 · NR

PKG and PKA Duo-Activation to Treat Cardiac Proteotoxicity

$484,772
Xuejun Wang · University Of South Dakota · R01 · FY2022 · HL

Oxidative Response Networks in Chagasic Cardiomyopathy

$484,768
Nisha Jain Garg · University Of Texas Med Br Galveston · R01 · FY2019 · AI

Evidence for Value-based Prescription Drug Plan for Diabetes, CVD and Chronic Illness

$484,729
Geoffrey F Joyce · University Of Southern California · R01 · FY2019 · AG

Reducing heart failure re-admissions by enhancing sleep apnea treatment adherence

$484,716
Eric Heil · Rightcare Solutions, Inc. · R44 · FY2016 · HL

Energetic State and Metabolic Remodeling in Cardiac Hypertrophy and Failure

$484,713
Qinglin Yang · Lsu Health Sciences Center · R01 · FY2025 · HL

Mayo Heart Failure Regional Clinical Center

$484,662
Margaret M Redfield · Mayo Clinic Rochester · U01 · FY2007 · HL

Nicotinamide riboside supplementation for treating elevated systolic blood pressure and arterial stiffness in middle-aged and older adults

$484,632
Douglas R Seals · University Of Colorado · R01 · FY2021 · AG

Pathophysiology of Osteoporosis

$484,606
Sundeep Khosla · Mayo Clinic Rochester · P01 · FY2017 · AG

Chronic Ischemic Mitral Regurgitation: Failure of a Mitral Control System?

$484,588
D Craig Miller · Stanford University · R01 · FY2010 · HL

Ca and Na Transport in Heart Failure

$484,586
Loyola University Chicago · R01 · FY2004 · HL

Imaging-based Indentification of Premature Ventricular Contraction-mediated

$484,516
Yuchi Han · Ohio State University · R01 · FY2024 · HL

Regulation of Cardiac Calcium Transport

$484,497
Seth L Robia · Loyola University Chicago · R01 · FY2020 · HL

Regulation of Cardiac Calcium Transport

$484,497
Seth L Robia · Loyola University Chicago · R01 · FY2019 · HL